A Systematic Review of Psychosocial Interventions in Treatment of Opioid Addiction

REFERENCES

• Ali, M. M., & Mutter, R. (2016). The CBHSQ Report: Patients who are privately insured recieve limited follow-up services after opioid-related hospitalization. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Retrieved from http://www.samhsa.gov/data/sites/default/files/report_2117/ShortReport-2117.html
   Google Scholar
• Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011). Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews, 10. doi:10.1002/14651858.CD004147
   Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.
   Google Scholar
• Barry, D., Cutter, C., Beitel, M., Liong, C., & Schottenfeld, R. (2015). Cognitive-behavioral therapy and educational counseling for chronic pain and opioid dependence. Drug and Alcohol Dependence, 146, e218–e219. doi:10.1016/j.drugalcdep.2014.09.062
   Google Scholar
• Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011). Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine, 12(4), 657–667. doi:10.1111/j.1526-4637.2011.01075.x
   PubMed Web of Science ®Google Scholar
• Bowen, S., Chawla, N., Collins, S. E., Witkiewitz, K., Hsu, S., Grow, J., … Marlatt, A. (2009). Mindfulness-based relapse prevention for substance use disorders: A pilot efficacy trial. Substance Abuse, 30(4), 295–305. doi:10.1080/08897070903250084
   PubMed Web of Science ®Google Scholar
• Bradizza, C. M., Stasiewicz, P. R., & Paas, N. D. (2006). Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review, 26(2), 162–178. doi:10.1016/j.cpr.2005.11.005
   PubMed Web of Science ®Google Scholar
• Brady, K. T., & Sinha, R. (2005). Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress. American Journal of Psychiatry, 162(8), 1483–1493. doi:10.1176/appi.ajp.162.8.1483
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2016). Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States, 2000–2014. Atlanta, GA: Author. Retrieved from http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf
   Google Scholar
• Cicero, T. J., Surratt, H., Inciardi, J. A., & Munoz, A. (2007). Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiology and Drug Safety, 16(8), 827–840. doi:10.1002/pds.1452
   PubMed Web of Science ®Google Scholar
• Crane, E. H. (2015). The CBHSQ Report: Emergency department visits involving narcotic pain relievers. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Retrieved from http://www.samhsa.gov/data/sites/default/files/report_2083/ShortReport-2083.html
   Google Scholar
• Dobkin, P. L., Civita, M. D., Paraherakis, A., & Gill, K. (2002). The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction, 97(3), 347–356. doi:10.1046/j.1360-0443.2002.00083.x
   PubMed Web of Science ®Google Scholar
• Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016). A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. Journal of Addiction Medicine, 10(2), 93–103. doi:10.1097/adm.0000000000000193
   PubMed Web of Science ®Google Scholar
• Fiellin, D. A., Barry, D. T., Sullivan, L. E., Cutter, C. J., Moore, B. A., O’Connor, P. G., & Schottenfeld, R. S. (2013). A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. The American Journal of Medicine, 126(1), 74.e11–74.e17. doi:10.1016/j.amjmed.2012.07.005
   PubMed Web of Science ®Google Scholar
• Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care, 54(10), 901–906. doi:10.1097/mlr.0000000000000625
   PubMed Web of Science ®Google Scholar
• Flynn, P. M., & Brown, B. S. (2008). Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment, 34(1), 36–47. doi:10.1016/j.jsat.2006.11.013
   PubMed Web of Science ®Google Scholar
• Garland, E. L., Manusov, E. G., Froeliger, B., Kelly, A., Williams, J. M., & Howard, M. O. (2014). Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: Results from an early-stage randomized controlled trial. Journal of Consulting and Clinical Psychology, 82(3), 448–459. doi:10.1037/a0035798
   PubMed Web of Science ®Google Scholar
• Gossop, M. (2006). Medically supervised withdrawal as stand-alone treatment. In E. C. Strain & M. L. Stitzer (Eds.), The treatment of opioid dependence (pp. 346–362). Baltimore, MD, USA: John Hopkins University Press.
   Google Scholar
• Governale, L. (2010). Outpatient prescription opioid utilization in the U.S., years 2000–2009. Retrieved from Anesthetic and Life Support Drugs Advisory Committee http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM220950.pdf
   Google Scholar
• Hansen, R. N., Oster, G., Edelsberg, J., Woody, G. E., & Sullivan, S. D. (2011). Economic costs of nonmedical use of prescription opioids. The Clinical Journal of Pain, 27(3), 194–202. doi:10.1097/AJP.0b013e3181ff04ca
   PubMed Web of Science ®Google Scholar
• Hartzler, B., Cotton, A. J., Calsyn, D. A., Guerra, R., & Gignoux, E. (2010). Dissolution of a harm reduction track for opiate agonist treatment: Longitudinal impact on treatment retention, substance use and service utilization. International Journal of Drug Policy, 21(1), 82–85. doi:10.1016/j.drugpo.2009.01.005
   PubMed Web of Science ®Google Scholar
• Hedden, S. L., Kennet, J., Lipari, R., Medley, G., Tice, P., Copello, E. S., & Kroutil, L. A. (2014). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf
   Google Scholar
• Lander, L. R., Gurka, K. K., Marshalek, P. J., Riffon, M., & Sullivan, C. R. (2015). A comparison of pregnancy-only versus mixed-gender group therapy among pregnant women with opioid use disorder. Social Work Research, 39(4), 235–244. doi:10.1093/swr/svv029
   Web of Science ®Google Scholar
• Ling, W., Hillhouse, M., Ang, A., Jenkins, J., & Fahey, J. (2013). Comparison of behavioral treatment conditions in buprenorphine maintenance. Addiction, 108(10), 1788–1798. doi:10.1111/add.12266
   PubMed Web of Science ®Google Scholar
• Lushin, V., & Anastas, J. W. (2011). Harm reduction in substance abuse treatment: Pragmatism as an epistemology for social work practice. Journal of Social Work Practice in the Addictions, 11(1), 96–100. doi:10.1080/1533256x.2011.546205
   Google Scholar
• Manchikanti, L., Helm, S., Fellows, B., Janata, J. W., Pampati, V., Grider, J. S., & Boswell, M. V. (2012). Opioid epidemic in the United States. Pain Physician, 15(3), ES9–ES38. Retrieved from http://www.painphysicianjournal.com/current/pdf?article=MTcwNA%3D%3D&journal=68
   PubMed Web of Science ®Google Scholar
• Marsch, L., Guarino, H., Acosta, M., Aponte-Melendez, Y., Cleland, C., Grabinski, M., … Edwards, J. (2014). Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment. Journal of Substance Abuse Treatment, 46(1), 43–51. doi:10.1016/j.jsat.2013.08.012
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrante Database of Systematic Reviews, 8, 1–31. doi:10.1002/14651858.cd002209.pub2
   Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. The Cochrane Library. doi:10.1002/14651858.cd002207
   Google Scholar
• Mitchell, S. G., Willet, J., Monico, L. B., James, A., Rudes, D. S., Viglioni, J., … Friedmann, P. D. (2016). Community correctional agents’ views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices. Substance Abuse, 37(1), 127–133. doi:10.1080/08897077.2015.1129389
   PubMed Web of Science ®Google Scholar
• Moore, B. A., Fiellin, D. A., Cutter, C. J., Buono, F. D., Barry, D. T., Fiellin, L. E., … Schottenfeld, R. S. (2016). Cognitive behavioral therapy improves treatment outcomes for prescription opioid users in primary care buprenorphine treatment. Journal of Substance Abuse Treatment, 71, 54–57. doi:10.1016/j.jsat.2016.08.016
   PubMed Web of Science ®Google Scholar
• NIDA. (2016). Effective treatments for opioid addiction. Retrieved from https://www.drugabuse.gov/publications/effective-treatments-opioid-addiction/effective-treatments-opioidaddiction
   Google Scholar
• Otto, M., Hearon, B., McHugh, R., Calkins, A., Pratt, E., Murray, H., … Pollack, M. (2014). A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. Journal of Psychoactive Drugs, 46(5), 402–411. doi:10.1080/02791072.2014.960110
   PubMed Web of Science ®Google Scholar
• Paulozzi, L. J., & Xi, Y. (2008). Recent changes in drug poisoning mortality in the United States by urban–Rural status and by drug type. Pharmacoepidemiology and Drug Safety, 17(10), 997–1005. doi:10.1002/pds.1626
   PubMed Web of Science ®Google Scholar
• Rossen, L. M., Bastian, B., Warner, M., Khan, D., & Chong, Y. (2016). Drug poisoning mortality: United States, 1999–2014. Centers for Disease Control and Prevention: National Center for Health Statistics. Retrieved from http://blogs.cdc.gov/nchs-data-visualization/drug-poisoning-mortality
   Google Scholar
• Schwartz, R. P. (2016). When added to opioid agonist treatment, psychosocial interventions do not further reduce the use of illicit opioids: A comment on Dugosh et al. Journal of Addiction Medicine, 10(4), 283–285. doi:10.1097/adm.0000000000000236
   PubMed Web of Science ®Google Scholar
• Schwartz, R. P., Kelly, S. M., O’Grady, K. E., Gandhi, D., & Jaffe, J. H. (2012). Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction, 107(5), 943–952. doi:10.1111/j.1360-0443.2011.03700.x
   PubMed Web of Science ®Google Scholar
• Smallwood, R. F., Potter, J. S., & Robin, D. A. (2016). Neurophysiological mechanisms in acceptance and commitment therapy in opioid-addicted patients with chronic pain. Psychiatry Research-Neuroimaging, 250, 12–14. doi:10.1016/j.pscychresns.2016.03.001
   PubMed Web of Science ®Google Scholar
• Stein, M. D., Herman, D. S., Moitra, E., Hecht, J., Lopez, R., Anderson, B. J., & Brown, R. A. (2015). A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine. Drug and Alcohol Dependence, 147, 243–250. doi:10.1016/j.drugalcdep.2014.11.007
   PubMed Web of Science ®Google Scholar
• Stotts, A., Green, C., Masuda, A., Grabowski, J., Wilson, K., Northrup, T., … Schmitz, J. (2012). A stage I pilot study of acceptance and commitment therapy for methadone detoxification. Drug and Alcohol Dependence, 125(3), 215–222. doi:10.1016/j.drugalcdep.2012.02.015
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2015a). Federal guidelines for opioid treatment programs. Retrieved from http://store.samhsa.gov/shin/content/PEP15-FEDGUIDEOTP/PEP15-FEDGUIDEOTP.pdf
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2015b). Results from the 2014 National Survey on Drug Use and Health: Detailed tables. Rockville, MD: SAMHSA Center for Behavioral Health Statistics and Quality. Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs2014/NSDUH-DetTabs2014.pdf
   Google Scholar
• Tetrault, J. M., Moore, B. A., Barry, D. T., O’Connor, P. G., Schottenfeld, R., Fiellin, D. A., & Fiellin, L. E. (2012). Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal of Substance Abuse Treatment, 43(4), 433–439. doi:10.1016/j.jsat.2012.07.011
   PubMed Web of Science ®Google Scholar
• Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010). A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review, 30(2), 155–166. doi:10.1016/j.cpr.2009.10.006
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies — Tackling the opioid-overdose epidemic. New England Journal of Medicine, 370(22), 2063–2066. doi:10.1056/NEJMp1402780
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., Griffin, M. L., Potter, J. S., Dodd, D. R., Dreifuss, J. A., Connery, H. S., & Carroll, K. M. (2014). Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine–Naloxone and standard medical management? Drug and Alcohol Dependence, 140, 118–122. doi:10.1016/j.drugalcdep.2014.04.005
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., … Ling, W. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase Randomized controlled trial. Archives of General Psychiatry, 68(12), 1238–1246. doi:10.1001/archgenpsychiatry.2011.121
   PubMed Web of Science ®Google Scholar
• Wright, E. R., Kooreman, H. E., Greene, M. S., Chambers, R. A., Banerjee, A., & Wilson, J. (2014). The iatrogenic epidemic of prescription drug abuse: County-level determinants of opioid availability and abuse. Drug and Alcohol Dependence, 138, 209–215. doi:10.1016/j.drugalcdep.2014.03.002
   PubMed Web of Science ®Google Scholar